For the Inventor, By the Inventor

Enter assignee name

Wilmington, DE, United States of America

Glaxosmithkline LLC

USPTO Granted Patents = 356

CIPO Patents = 31

EPO Patents = 167

Trademarks = 134

Forward Citations = 2,530

Loading Chart...

Loading Chart...

650 inventors (with patents filed for the assignee):

Diane Mary Coe (18 out of 40 patents)

Stephen Allan Smith (17 out of 42 patents)

William Henry Miller (15 out of 73 patents)

4. Steven David Knight (15 out of 50 patents)

5. Mui Cheung (13 out of 43 patents)

6. Ralph A Rivero (13 out of 14 patents)

7. Rosanna Tedesco (12 out of 12 patents)

8. Snigdha Mishra (12 out of 12 patents)

9. Meagan B Rouse (12 out of 18 patents)

10. Gustav R Fenton (12 out of 15 patents)

11. Xinrong Tian (11 out of 15 patents)

12. Junya Qu (10 out of 11 patents)

13. Emmanuel Hubert Demont (10 out of 23 patents)

14. Neil W Johnson (10 out of 20 patents)

15. Jeffrey S Brunner (10 out of 10 patents)

Core Competencies:

Prolyl Hydroxylase Inhibitors

Biopharmaceutical Compositions

Eosinophilic Bronchitis Treatment

PI3 Kinase Inhibitors

Sirtuin Modulators

Diacylglycerol Acyltransferase Inhibitors

Bromodomain Inhibitors

HIV Treatment Compounds

356 patents: Sort by Forward Citations

1. RE50497 - (N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide (2025-07-22),

2. D1042109 - Package (2024-09-17),

3. 11963962 - Platelet count-agnostic methods of treating myelofibrosis (2024-04-23),

4. 11643397 - Prolyl hydroxylase inhibitors (2023-05-09),

5. 11390671 - Biopharmaceutical compositions and methods for pediatric patients (2022-07-19),

6. 11325972 - Methods of treatment of eosinophilic bronchitis with an anti-IL-5 antibody (2022-05-10),

7. D920093 - Package (2021-05-25),

8. 10745449 - UspA2 protein constructs and uses thereof (2020-08-18),

9. 10660898 - Benzimidazole derivatives as PI3 kinase inhibitors (2020-05-26),

10. 10590135 - Substituted bridged urea analogs as sirtuin modulators (2020-03-17),

11. 10478426 - Enhancer of Zeste Homolog 2 inhibitors (2019-11-19),

12. 10392625 - Host cells and methods of use (2019-08-27),

13. 10391717 - Package and heat sealing device (2019-08-27),

14. 10385066 - Compounds as diacylglycerol acyltransferase inhibitors (2019-08-20),

15. 10357798 - Vapor sheath for liquid dispensing nozzle (2019-07-23),

GlaxoSmithKline LLC is a leading British pharmaceutical and healthcare company. With a mission to improve the quality of human life, GSK specializes in research, development, manufacturing, and marketing of pharmaceutical products, vaccines, and consumer healthcare products. GSK focuses on areas such as respiratory, HIV/AIDS, vaccines, immuno-inflammation, and oncology. Visit their website for more information and to explore their diverse portfolio of products.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

356 Patents

#23 in Wilmington, DE

#32 in Delaware

#1,230 in US

#2,491 in the World

Wilmington, DE, United States of America

Glaxosmithkline LLC

Forward Citations = 2,530

650 inventors:

Diane Mary Coe (18 out of 40 patents)

Stephen Allan Smith (17 out of 42 patents)

William Henry Miller (15 out of 73 patents)

4. Steven David Knight (15 out of 50 patents)

5. Mui Cheung (13 out of 43 patents)

Please report any incorrect information to support@idiyas.com

Loading…